Related references
Note: Only part of the references are listed.Cells with stem-like properties are associated with the development of HPV18-positive cervical cancer
Misako Kusakabe et al.
CANCER SCIENCE (2023)
Factors Correlated with the Accuracy of Colposcopy-Directed Biopsy: A Systematic Review and Meta-Analysis
Hongyan Ren et al.
JOURNAL OF INVESTIGATIVE SURGERY (2022)
Misoprostol and estradiol to enhance visualization of the transformation zone during cervical cancer screening: An integrative review
Simon M. Manga et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2022)
Annual report of the Committee on Gynecologic Oncology, the Japan Society of Obstetrics and Gynecology: Annual Patient Report for 2018 and Annual Treatment Report for 2013
Satoru Nagase et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2022)
Prognosis of high-risk human papillomavirus-related cervical lesions: A hidden Markov model analysis of a single-center cohort in Japan
Ryo Ikesu et al.
CANCER MEDICINE (2022)
Genomic characterization of small cell carcinomas of the uterine cervix
Anne M. Schultheis et al.
MOLECULAR ONCOLOGY (2022)
A Therapeutic Antigen-Presenting Cell-Targeting DNA Vaccine VB10.16 in HPV16-Positive High-Grade Cervical Intraepithelial Neoplasia: Results from a Phase I/IIa Trial
Peter Hillemanns et al.
CLINICAL CANCER RESEARCH (2022)
Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Hyuna Sung et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2021)
TCR-engineered T cells targeting E7 for patients with metastatic HPV-associated epithelial cancers
Nisha B. Nagarsheth et al.
NATURE MEDICINE (2021)
Efficacy and safety of tisotumab vedotin in previously treated recurrent or metastatic cervical cancer (innovaTV 204/GOG-3023/ENGOT-cx6): a multicentre, open-label, single-arm, phase 2 study
Robert L. Coleman et al.
LANCET ONCOLOGY (2021)
A Placebo-Controlled, Double-Blind Randomized (Phase IIB) Trial of Oral Administration with HPV16 E7-Expressing Lactobacillus, GLBL101c, for the Treatment of Cervical Intraepithelial Neoplasia Grade 2 (CIN2)
Yuji Ikeda et al.
VACCINES (2021)
Pembrolizumab for Persistent, Recurrent, or Metastatic Cervical Cancer
N. Colombo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
The Natural History of Cervical Intraepithelial Neoplasia Grades 1, 2, and 3: A Systematic Review and Meta-analysis
Diede L. Loopik et al.
JOURNAL OF LOWER GENITAL TRACT DISEASE (2021)
Multistate Markov Model to Predict the Prognosis of High-Risk Human Papillomavirus-Related Cervical Lesions
Ayumi Taguchi et al.
CANCERS (2020)
Glassy cell carcinoma of cervix: an analysis for 20 cases and literatures review
Qingxuan Wang et al.
TRANSLATIONAL CANCER RESEARCH (2020)
Cervical cancer screening for individuals at average risk: 2020 guideline update from the American Cancer Society
Elizabeth T. H. Fontham et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
HPV Vaccination and the Risk of Invasive Cervical Cancer
Jiayao Lei et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Manipulation of JAK/STAT Signalling by High-Risk HPVs: Potential Therapeutic Targets for HPV-Associated Malignancies
Ethan L. Morgan et al.
VIRUSES-BASEL (2020)
Feasibility and utility of a panel testing for 114 cancer-associated genes in a clinical setting: A hospital-based study
Kuniko Sunami et al.
CANCER SCIENCE (2019)
Carboplatin/paclitaxel, E7-vaccination and intravaginal CpG as tri-therapy towards efficient regression of genital HPV16 tumors
Sonia Domingos-Pereira et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
Recent advances in invasive adenocarcinoma of the cervix
Simona Stolnicu et al.
VIRCHOWS ARCHIV (2019)
From HPV Infection to Lesion Progression: The Role of HLA Alleles and Host Immunity
Anna Paaso et al.
ACTA CYTOLOGICA (2019)
The projected timeframe until cervical cancer elimination in Australia: a modelling study
Michaela T. Hall et al.
LANCET PUBLIC HEALTH (2019)
Tumor-associated CD204+ M2 macrophages are unfavorable prognostic indicators in uterine cervical adenocarcinoma
Asuka Kawachi et al.
CANCER SCIENCE (2018)
Beyond resumption of the Japanese Government's recommendation of the HPV vaccine
Yutaka Ueda et al.
LANCET ONCOLOGY (2018)
Papillomaviruses: a systematic review
Rodrigo Pinheiro Araldi et al.
GENETICS AND MOLECULAR BIOLOGY (2017)
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
Krishnansu S. Tewari et al.
LANCET (2017)
Integrated genomic and molecular characterization of cervical cancer
Robert D. Burk et al.
NATURE (2017)
Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients
Ahmet Zehir et al.
NATURE MEDICINE (2017)
Clinical Significance of CD163+and CD68+Tumor-associated Macrophages in High-risk HPV-related Cervical Cancer
Xiao-Jing Chen et al.
JOURNAL OF CANCER (2017)
Correlation of E6 and E7 levels in high-risk HPV16 type cervical lesions with CCL20 and Langerhans cells
B. Jiang et al.
GENETICS AND MOLECULAR RESEARCH (2015)
Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus-Targeted Tumor-Infiltrating T Cells
Sanja Stevanovic et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Safety, efficacy, and immunogenicity of VGX-3100, a therapeutic synthetic DNA vaccine targeting human papillomavirus 16 and 18 E6 and E7 proteins for cervical intraepithelial neoplasia 2/3: a randomised, double-blind, placebo-controlled phase 2b trial
Cornelia L. Trimble et al.
LANCET (2015)
Genome-wide profiling of HPV integration in cervical cancer identifies clustered genomic hot spots and a potential microhomology-mediated integration mechanism
Zheng Hu et al.
NATURE GENETICS (2015)
The human papillomavirus (HPV) E7 protein antagonises an Imiquimod-induced inflammatory pathway in primary human keratinocytes
Kathryn H. Richards et al.
SCIENTIFIC REPORTS (2015)
Human Papillomavirus Genotype Distribution in Cervical Intraepithelial Neoplasia Grade 2/3 and Invasive Cervical Cancer in Japanese Women
Yukari Azuma et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2014)
Landscape of genomic alterations in cervical carcinomas
Akinyemi I. Ojesina et al.
NATURE (2014)
The Prevalence Of Cervical Regulatory T Cells in HPV-Related Cervical Intraepithelial Neoplasia (CIN) Correlates Inversely with Spontaneous Regression of CIN
Satoko Kojima et al.
AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY (2013)
The Human papillomavirus type 16 E7 oncoprotein induces a transcriptional repressor complex on the Toll-like receptor 9 promoter
Uzma A. Hasan et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
High-risk human papillomavirus E6 inhibits monocyte differentiation to Langerhans cells
Norifumi Iijima et al.
VIROLOGY (2013)
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer
Debbie Saslow et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
HLA Class II DRB1*1302 Allele Protects Against Progression to Cervical Intraepithelial Neoplasia Grade 3 A Multicenter Prospective Cohort Study
Koji Matsumoto et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2012)
A discrete population of squamocolumnar junction cells implicated in the pathogenesis of cervical cancer
Michael Herfs et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Predicting the progression of cervical precursor lesions by human papillomavirus genotyping: a prospective cohort study
Koji Matsumoto et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
The PD-1 pathway in tolerance and autoimmunity
Loise M. Francisco et al.
IMMUNOLOGICAL REVIEWS (2010)
Down-Regulation of HLA Class I Antigen in Human Papillomavirus Type 16 E7 Expressing HaCaT Cells Correlate With TAP-1 Expression
Wei Li et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2010)
CD1d, a Sentinel Molecule Bridging Innate and Adaptive Immunity, Is Downregulated by the Human Papillomavirus (HPV) E5 Protein: a Possible Mechanism for Immune Evasion by HPV
Shiho Miura et al.
JOURNAL OF VIROLOGY (2010)
HPV-16 E5 down-regulates expression of surface HLA class I by CD8 T cells
M. S. Campo et al.
VIROLOGY (2010)
Human papillomavirus DNA versus papanicolaou screening tests for cervical cancer
Marie-Helene Mayrand et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
CD4+CD25hi regulatory T-cell frequency correlates with persistence of human papillomavirus type 16 and T helper cell responses in patients with cervical intraepithelial neoplasia
Johan W. Molling et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: Roles of E6 and E7 proteins
Mako Narisawa-Saito et al.
CANCER SCIENCE (2007)
The contribution of HPV18 to cervical cancer is underestimated using high-grade CIN as a measure of screening efficiency
S. Bulk et al.
BRITISH JOURNAL OF CANCER (2007)
Role of hormone cofactors in the human papillomavirus-induced carcinogenesis of the uterine cervix
Philippe Delvenne et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2007)
The natural history of cervical HPV infection: unresolved issues
Ciaran B. J. Woodman et al.
NATURE REVIEWS CANCER (2007)
HLA-B alleles, high-risk HPV infection and risk for cervical neoplasia in southern Chinese women
PKS Chan et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
High-risk human papilloma virus infection decreases the frequency of dendritic Langerhans' cells in the human female genital tract
R Jimenez-Flores et al.
IMMUNOLOGY (2006)
Decreased migration of Langerhans precursor-like cells in response to human keratinocytes expressing human papillomavirus type 16 E6/E7 is related to reduced macrophage inflammatory protein-3α production
JC Guess et al.
JOURNAL OF VIROLOGY (2005)
Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women
C Clavel et al.
BRITISH JOURNAL OF CANCER (2001)
Inactivation of interferon regulatory factor-1 tumor suppressor protein by HPV E7 oncoprotein - Implication for the E7-mediated immune evasion mechanism in cervical carcinogenesis
JS Park et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
